Capsular Polysaccharide Segment Held Largest Share of Typhoid Fever Vaccines Market during forecast period
According to The Insight Partners market research study of “Asia Pacific Typhoid Fever Vaccines Market Forecast to 2027 - Covid-19 Impact and Analysis by Vaccine Type and Route Of Administration,” Asia Pacific typhoid fever vaccines market is projected to reach US$ 135.79 million in 2027 from US$ 64.75 million in 2019. The market is estimated to grow at CAGR of 10.0% from 2020 to 2027. The report highlights trends prevailing in the Asia Pacific typhoid fever vaccines market and the factors driving market along with those that act as hindrances.
The typhoid fever vaccines market, based on vaccine type, is further segmented into live attenuated vaccine, capsular polysaccharide vaccines, conjugate vaccine, and others. The capsular polysaccharide vaccines segment held the largest share of the market in 2019, whereas the live attenuated vaccine segment is anticipated to register the highest CAGR of in the market during the forecast period. Polysaccharide (PS) vaccines are antibacterial vaccines with unique characteristics and their main advantage is simplicity of production and high effectiveness against the bacteria.
Asia Pacific typhoid fever vaccines market is expected to grow owing to key factors such as increasing prevalence of typhoid fever in Asia and typhoid immunizations programs. However, risks associated with typhoid fever vaccines is likely to have a negative impact on the growth of the market in the coming years.
Leading companies operating in the Asia Pacific typhoid fever vaccines market are GlaxoSmithKline plc, Shanghai institute of biological products co., ltd., PT Bio Farma, BIO-MED, BHARAT BIOTECH among others.
Asia Pacific Typhoid Fever Vaccines Market, By Country, 2019 (% share) Asia Pacific Typhoid Fever Vaccines Market Forecast to 2027 - Covid-17 Impact and Regional Analysis by Vaccine Type (Live Attenuated Vaccine, Capsular Polysaccharide Vaccines, Conjugate Vaccine and Others) and Route of administration (Oral and Injectable) and Country
Asia Pacific Typhoid Fever Vaccines Market to Grow at a CAGR of 10.0% to reach US$ 135.79 Million from 2020 to 2027
Download Free Sample
The report segments Asia Pacific Typhoid Fever Vaccines market as follows:
- Live Attenuated Vaccine
- Capsular Polysaccharide Vaccines
- Conjugate Vaccine
- Others
By Route of Administration
- Oral
- Injectable
By Country
- India
- China
- Japan
- South Korea
- Australia
- Rest of Asia Pacific